German BfArM Introduces New Regulation for Pharmaceutical Packaging Size Metrics
Germany's Federal Institute for Drugs and Medical Devices (BfArM) has issued a new administrative regulation concerning the assignment of metrics for pharmaceutical packaging sizes. The regulation became effective on March 6, 2026.
The Federal Institute for Drugs and Medical Devices (BfArM) in Germany has introduced a new administrative regulation impacting the allocation of metrics for pharmaceutical packaging sizes. The regulation was officially published in the Bundesanzeiger, Germany's federal gazette, on Friday, March 6, 2026.
This new directive outlines the procedures and requirements for pharmaceutical companies seeking specific metrics for their product packaging. These metrics can influence various aspects of a drug's market presence in Germany, including its reimbursement status and pricing.
The introduction of the regulation also includes an extension of the deadline for submitting final technical information related to the metric assignment process. This extension offers pharmaceutical manufacturers additional time to comply with the updated requirements.
Pharma Deutschland e.V., an industry association, communicated the update to its members. The BfArM's action signifies a continued effort by German regulatory authorities to oversee the pharmaceutical market and ensure appropriate standards for products available to patients.